Treating patients with severe psoriasis is not nearly as frustrating as it used to be. In this issue, two articles describe the use of ustekinumab for psoriasis. Elizabeth Wilder and…

Hyperhidrosis is defined as non-physiological, excessive sweating that is not caused by physical activity, which occurs in a localized, symmetrical distribution. It affects from 2.8% - 5% of the population…

As the use of new chemotherapeutic agents becomes more common, the associated side effects increase. Sorafenib tosylate (Nexavar® tablets, Bayer Healthcare Pharmaceuticals Inc.) is approved for use in the treatment…

Bowenoid papulosis (BP) is an uncommon squamous intraepithelial neoplasia, which manifests as an eruption of flesh colored or hyperpigmented verrucous papules that may become confluent plaques, involving the genitalia and…

INTRODUCTION Herbal medicine, also referred to as botanical medicine and phytomedicine, has steadily gained popularity as an alternative to conventional, synthetic drug use.1 In 2007, 1 out of 4 adults…

INTRODUCTIONPsoriasis is a chronic and complex genetic immune-mediated disease affecting up to 2% of the US population.1 The pathogenesis of psoriasis stems from dysregulated inflammation, which leads to hyperproliferation of…

INTRODUCTION Psoriasis is a chronic, incurable skin disease affecting millions of people worldwide. Nail abnormalities occur concomitantly in 50% of patients with psoriasis, with a lifetime incidence of 80% to…

INTRODUCTIONA 2004 study determined that the prevalence of diagnosed psoriasis was 3.15%, which is the equivalent of approximately 5 million adults, while the National Psoriasis Foundation estimates that the number…

INTRODUCTION Psoriasis is a chronic autoimmune disease that affects 2-3% of adults.1 Despite newer oral and injectable systemic treatment options, phototherapy remains prevalent in disease therapy. Ultraviolet-B (UVB) phototherapy involves…

INTRODUCTIONWith nearly 50 years of use, methotrexate is a mainstay of therapy for psoriasis. Appropriate patient selection and careful monitoring provides safe and reliable use for a reasonable cost.1-4 Methotrexate…

INTRODUCTION Psoriasis is a chronic skin condition affecting approximately 2-3% of the U.S. population and worldwide.1 About 15-40% of those with psoriasis also have psoriatic arthritis. Those with psoriatic arthritis…

INTRODUCTIONAn evolving theme in the field of cutaneous oncology is the use of personalized or targeted therapy for the treatment of advanced disease. Targeted therapy is the identification of the…